DATE: Thursday, June 25th, 2009 TIME: 2:00 pm ET / 11:00 am PT REGISTER NOW: https://www.conferenceplus.com/confcenter/PinCode/Pin_Code.aspx?100185&o=70542468205616"The pharmaceutical industry's negative public perception has caused key opinion leaders to question whether relationships with drug makers will negatively affect their reputations," said Elio Evangelista, key presenter at the upcoming webinar. "Many KOLs now pose their own roadblocks to building relationships. I will be introducing the top six challenges we have found thought leader management groups must overcome to succeed at building and maintaining these relationships." Mr. Evangelista has led Cutting Edge Information's thought leader development research since 2002. His work on fair-market value compensation and MSL program performance has been cited in the Journal of Clinical Research Best Practices. Mr. Evangelista regularly speaks on the topics of relationship building, KOL compensation, MSL interactions and activities, and trends affecting thought leader management. The webinar will also cover how recent regulatory and policy changes, such as PhRMA code and ACCME guideline amendments, will impact thought leader development teams. Learn what pharmaceutical executives can do to build relationships with new thought leaders within a shrinking opinion leader pool. Find out why transparency and fair-market value processes continue to play a significant role in setting strategy for thought leader development teams. For more information about Cutting Edge Information's medical affairs and thought leader research, visit: http://www.cuttingedgeinfo.com/reports/medical-affairs.php
Contact Information: CONTACT: Stephanie Swanson 919-433-0212